Now there are a few cases in, say with pharmaceuticals where it might cost you a billion dollars to do a phase three human trial, but then subsequently the drug is very cheap to manufacture. So cases. There are some, In my opinion, we should massively reduce what can be patented. Because the whole point of patenting is to maximize innovation, not inhibit it. And in my opinion, maybe a controversial opinion, most patents inhibit innovation, they do not help it. (22:05–22:09)
CLAIM
Asserts that the scope of patentable items should be significantly reduced.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
_(cropped).jpg)